| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 47,773 | 45,974 | 47,497 | 44,813 | | Cost of Revenue | 28,083 | 23,538 | 30,501 | 28,805 | | | Gross Profit | (24,716) | 22,436 | 16,996 | 16,008 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,468 | 5,958 | 6,989 | 10,121 | | Non Recurring | 30,639 |
-
|
-
|
-
| | Others | 6,990 | 8,202 | 7,799 | 8,416 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (70,813) | 8,276 | 2,208 | (2,529) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (32,502) | (20,655) | 5,904 | 2,375 | | Earnings Before Interest And Taxes | (58,669) | (12,576) | 8,112 | (3,947) | | Interest Expense | (44,087) | 23,072 | 21,015 | 26,378 | | Income Before Tax | (14,582) | (35,648) | (12,903) | (30,325) | | Income Tax Expense | (1,191) | (709) | (1,521) | (4,386) | | Minority Interest | 8,548 |
-
|
-
| 311 | | | | Net Income From Continuing Ops | (13,391) | (34,939) | (11,382) | (25,939) | | | Non-recurring Events | | Discontinued Operations | 2,289 | 1,315 | 3,093 | 8,440 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,554) | (33,624) | (8,289) | (17,499) | | Preferred Stock And Other Adjustments | (7,645) | 4,716 | 1,063 | (618) | | | Net Income Applicable To Common Shares | ($10,199) | ($28,908) | ($7,226) | ($18,117) |
|
0.51% Nasdaq 
0.01 (0.08%) 
Income Statement
